Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Potential of an mRNA-Based Urine Assay (Xpert® Bladder Cancer Detection1) in Hematuria Patients - Results from a Cohort Study.
Schmitz-Dräger C, Goebell PJ, Paxinos E, Bismarck E, Chen J, Balakrishnan P, Bates M, Ebert T, Schmitz-Dräger BJ, Benderska-Söder N. Schmitz-Dräger C, et al. Among authors: benderska soder n. Bladder Cancer. 2024 Mar 12;10(1):25-33. doi: 10.3233/BLC-230089. eCollection 2024. Bladder Cancer. 2024. PMID: 38993527 Free PMC article.
Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer.
Benderska-Söder N, Ecke T, Kleinlein L, Roghmann F, Bismarck E, van Rhijn BWG, Stenzl A, Witjes JA, Todenhöfer T, Hakenberg OW, Grimm MO, Goebell PJ, Burger M, Jensen JB, Schmitz-Dräger BJ. Benderska-Söder N, et al. Urol Oncol. 2024 Aug;42(8):229-235. doi: 10.1016/j.urolonc.2024.01.025. Epub 2024 Feb 24. Urol Oncol. 2024. PMID: 38403529 Review.
Lifestyle aspects in a contemporary middle-European cohort of patients undergoing androgen deprivation therapy for advanced prostate cancer: data from the non-interventional LEAN study.
Schmitz-Dräger BJ, Bismarck E, Grammenos D, Ebert T, Starlinger R, Ottillinger B, Goebell PJ, Mühlich S, Benderska-Söder N, Hakenberg O. Schmitz-Dräger BJ, et al. Among authors: benderska soder n. Br J Nutr. 2023 Aug 14;130(3):495-502. doi: 10.1017/S0007114522003452. Epub 2022 Nov 10. Br J Nutr. 2023. PMID: 36352765 Free PMC article.
Discriminative capacity of guideline recommendations in the assessment of patients with asymptomatic microhematuria.
Kuckuck EC, Hennenlotter J, Todenhöfer T, Brünn LA, Rass GC, Stenzl A, Hakenberg OW, Roghmann F, Goebell PJ, Grimm MO, Pycha A, Bolenz C, Burger M, Benderska-Söder N, Schmitz-Dräger BJ. Kuckuck EC, et al. Among authors: benderska soder n. Urol Oncol. 2023 May;41(5):254.e1-254.e8. doi: 10.1016/j.urolonc.2022.08.011. Epub 2022 Oct 21. Urol Oncol. 2023. PMID: 36274029
Sensitivity and Specificity in Urine Bladder Cancer Markers - Is it that Simple?
Roghmann F, Goebell PJ, Dyrskjøt L, van Rhijn BWG, Käfferlein HU, Hakenberg O, Stenzl A, Burger M, Pesch B, Benderska-Söder N, Schmitz-Dräger BJ. Roghmann F, et al. Among authors: benderska soder n. Bladder Cancer. 2022 Mar 11;8(1):1-4. doi: 10.3233/BLC-211602. eCollection 2022. Bladder Cancer. 2022. PMID: 38994515 Free PMC article.
[Rational follow-up of non-muscle invasive bladder cancer].
von Landenberg N, Benderska-Söder N, Bismarck E, Kernig K, Erne E, Goebell PJ, Schmitz-Dräger BJ. von Landenberg N, et al. Among authors: benderska soder n. Urologe A. 2021 Nov;60(11):1409-1415. doi: 10.1007/s00120-021-01683-6. Epub 2021 Oct 15. Urologe A. 2021. PMID: 34652477 Review. German.
Effectiveness and Distribution of Testosterone Levels within First Year of Androgen Deprivation Therapy in a Real-World Setting: Results from the Non-Interventional German Cohort LEAN Study.
Schmitz-Dräger BJ, Mühlich S, Lange C, Benderska-Söder N, Bismarck E, Starlinger R, Ottillinger B, Hakenberg OW. Schmitz-Dräger BJ, et al. Among authors: benderska soder n. Urol Int. 2021;105(5-6):436-445. doi: 10.1159/000513073. Epub 2021 Feb 25. Urol Int. 2021. PMID: 33631760 Free PMC article.
Eosinophilic cystitis mimicking bladder cancer-considerations on the management based upon a case report and a review of the literature.
Schmitz-Dräger BJ, Skutetzki A, Rieker RJ, Schwab SA, Stöhr R, Bismarck E, Savov O, Ebert T, Benderska-Söder N, Hartmann A. Schmitz-Dräger BJ, et al. Among authors: benderska soder n. Virchows Arch. 2021 Sep;479(3):523-527. doi: 10.1007/s00428-021-03049-x. Epub 2021 Feb 12. Virchows Arch. 2021. PMID: 33576854 Review.
Toward noninvasive follow-up of low-risk bladder cancer - Rationale and concept of the UroFollow trial.
Benderska-Söder N, Hovanec J, Pesch B, Goebell PJ, Roghmann F, Noldus J, Rabinovich J, Wichert K, Gleichenhagen J, Käfferlein HU, Köhler CU, Johnen G, Kernig K, Hakenberg O, Jahn D, Todenhöfer T, Stenzl A, Gleissner J, Gerwert K, El-Mashtoly S, Behrens T, Brüning T, Schmitz-Dräger BJ. Benderska-Söder N, et al. Urol Oncol. 2020 Dec;38(12):886-895. doi: 10.1016/j.urolonc.2020.01.006. Epub 2020 Mar 18. Urol Oncol. 2020. PMID: 32199755 Review.